Amyloid-β 1-40 as an Independent Cardiovascular Risk Factor: First Evidence in Patients With Cardiovascular Disease

被引：0
|
作者：
Stellos, Konstantinos [1 ]
Sibbing, Dirk [2 ]
Stakos, Dimitrios [3 ]
Georgiopoulos, Georgios [4 ]
Braun, Siegmund [5 ]
Gatsiou, Aikaterini [1 ]
Sopova, Kateryna [1 ]
Kastritis, Efstathios [4 ]
Alevizaki, Maria [4 ]
Kastrati, Adnan [6 ]
Stamatelopoulos, Kimon [4 ]
机构：
[1] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Vasc Inflammat Grp, D-60054 Frankfurt, Germany
[2] Univ Munich LMU, Dept Cardiol, Munich, Germany
[3] Democritus Univ Thrace, Dept Cardiol, Alexandroupolis, Greece
[4] Univ Athens, Dept Clin Therapeut, Athens, Greece
[5] Deutsch Herzzentrum Munich, Munich, Greece
[6] Deutsch Herzzentrum Munich, Dept Cardiol, Munich, Germany
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Biomarkers; Coronary heart disease; Subclinical atherosclerosis; Cardiovascular disease; Arteriosclerosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12474
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Asymmetric dimethylarginine as a novel independent risk factor for cardiovascular disease in haemodialysis patients
    Vesela, Eugenie
    Siroka, Romana
    Eiselt, Jaromir
    Malanova, Lada
    Racek, Jaroslav
    Trefil, Ladislav
    Rajdl, Daniel
    Cibulka, Roman
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 435 - 435
  • [32] Pulse pressure is an independent risk factor of cardiovascular disease in renal transplant patients
    Fernández-Fresnedo, G
    Escallada, R
    Rodrigo, E
    de Francisco, ALM
    de Castro, SS
    Ruiz, JC
    Piñera, C
    Cotorruelo, JG
    Arias, M
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1730 - 1731
  • [33] Heart rate as an independent risk factor for, cardiovascular disease - Current evidence and basic mechanisms
    Palatini, Paolo
    DRUGS, 2007, 67 (Suppl 2) : 3 - 13
  • [34] Red cell interactions with amyloid-β1-40 fibrils in a murine model
    Ravi, LB
    Poosala, S
    Ahn, D
    Chrest, FJ
    Spangler, EL
    Jayakumar, R
    Nagababu, E
    Mohanty, JG
    Talan, M
    Ingram, DK
    Rifkind, JM
    NEUROBIOLOGY OF DISEASE, 2005, 19 (1-2) : 28 - 37
  • [35] Probing the amyloid-β(1-40) fibril environment with substituted tryptophan residues
    Touchette, Jillienne C.
    Williams, Laura L.
    Ajit, Deepa
    Gallazzi, Fabio
    Nichols, Michael R.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 494 (02) : 192 - 197
  • [36] Prevention of Amyloid-β Fibril Formation Using Antibodies Against the C-terminal Region of Amyloid-β1-40 and Amyloid-β1-42
    Montanes, Maria
    Casabona, Diego
    Sarasa, Leticia
    Pesini, Pedro
    Sarasa, Manuel
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (01) : 133 - 137
  • [37] Change and stabilization of the amyloid-β(1-40) secondary structure by fluorocompounds.
    Vieira, EP
    Hermel, H
    Möhwald, H
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2003, 1645 (01): : 6 - 14
  • [38] Critical aggregation concentration and reversibility of amyloid-(3(1-40) oligomers
    Illodo, Sara
    Al-Soufi, Wajih
    Novo, Mercedes
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 761
  • [39] Cryo-EM structures of lipidic fibrils of amyloid-β (1-40)
    Benedikt Frieg
    Mookyoung Han
    Karin Giller
    Christian Dienemann
    Dietmar Riedel
    Stefan Becker
    Loren B. Andreas
    Christian Griesinger
    Gunnar F. Schröder
    Nature Communications, 15
  • [40] EVIDENCE FOR AN INDEPENDENT ASSOCIATION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH NARCOLEPSY
    Kaufmann, Christopher
    Riaz, Munaza
    Park, Haesuk
    Lo-Ciganic, Wei-Hsuan
    Wilson, Debbie
    Malhotra, Atul
    Wickwire, Emerson
    Bhattacharjee, R.
    SLEEP, 2024, 47 : A368 - A368
12345